Author

V. Shinde

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 2 Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Research Focus:host-pathogen & immune response· 2 Organism:human· 2 Assay:proteomics· 2 Research Focus:cell signaling & trafficking· 1 Research Focus:cell type annotation· 1 Assay:clinical cohort / trial· 1 Research Focus:drug response / drug discovery· 1

Frequent Co-Authors

G. Glenn· 2 shared A. D. Portnoff· 1 shared A. Koen· 1 shared B. E. Lambson· 1 shared B. Zhou· 1 shared C. Bennett· 1 shared C. Crowther· 1 shared C. Grobbelaar· 1 shared

Activity by Year

2021-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 31 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersImmunology

G. Glenn

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

A vector system for single and tandem expression of cloned genes and multi-colour fluorescent tagging in Haloferax volcanii

S. Ithurbide, R. T. de Silva, H. J. Brown, V. Shinde, I. G. Duggin

The paper develops a plasmid vector system for cloning and expressing genes with fluorescent tags in Haloferax volcanii, enabling functional studies of protein fusions.

bioRxiv · Mar 13, 2024 · PreprintMicrobiology

Novavax NVX-COV2373 triggers potent neutralization of Omicron sub-lineages

J. N. Bhiman, S. I. Richardson, B. E. Lambson, P. Kgagudi, N. Mzindle, H. Kaldine, C. Crowther, G. Gray, L.-G. Bekker, A. Koen, L. Fairlie, L. Fouche, Q. Bhorat, K. Dheda, M. Tameris, , P. L. Moore

This study evaluates the neutralizing antibody response to NVX-CoV2373 against Omicron sub-lineages after two or three doses, showing improved neutralization with a third dose.

bioRxiv · Jul 14, 2022 · PreprintImmunology

Combination Respiratory Vaccine Containing Recombinant SARS-CoV-2 Spike and QuadrivalentSeasonal Influenza Hemagglutinin Nanoparticles with Matrix-M Adjuvant

M. J. Massare, N. Patel, B. Zhou, S. Maciejewski, R. Flores, M. Guebre-Xabier, J.-H. Tian, A. D. Portnoff, L. Fries, V. Shinde, L. R. Ellingsworth, G. Glenn, G. Smith

This paper evaluates a combination vaccine against seasonal influenza and SARS-CoV-2 in animal models, showing it induces protective immune responses and prevents viral replication and disease.

bioRxiv · May 5, 2021 · PreprintImmunology